Impact of pre-admission physical activity on benefits of physiology-guided complete revascularization in older patients with myocardial infarction: insights from the FIRE trial.

Coronary artery disease Elderly Exercise Myocardial infarction Myocardial revascularization

Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
07 Mar 2024
Historique:
received: 30 10 2023
revised: 31 12 2023
accepted: 05 02 2024
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: aheadofprint

Résumé

The present analysis from the Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial aims to explore the significance of pre-admission physical activity and assess whether the benefits of physiology-guided complete revascularization apply consistently to sedentary and active older patients. Patients aged 75 years or more with myocardial infarction (MI) and multivessel disease were randomized to receive physiology-guided complete revascularization or culprit-only strategy. The primary outcome was a composite of death, MI, stroke, or any revascularization within a year. Secondary endpoints included the composite of cardiovascular death or MI, as well as single components of the primary endpoint. Pre-admission physical activity was categorized into three groups: (i) absent (sedentary), (ii) light, and (iii) vigorous. Among 1445 patients, 692 (48%) were sedentary, whereas 560 (39%) and 193 (13%) performed light and vigorous physical activity, respectively. Patients engaging in light or vigorous pre-admission physical activity exhibited a reduced risk of the primary outcome compared with sedentary individuals [light hazard ratio (HR) 0.70, 95% confidence interval (CI) 0.55-0.91 and vigorous HR 0.14, 95% CI 0.07-0.91, respectively]. These trends were also observed for death, cardiovascular death, or MI. When comparing physiology-guided complete revascularization vs. culprit-only strategy, no significant interaction was observed for primary and secondary endpoints when stratified by sedentary or active status. In older patients with MI, pre-admission physical activity emerges as a robust and independent prognostic determinant. Physiology-guided complete revascularization stands out an effective strategy in reducing ischaemic adverse events, irrespective of pre-admission physical activity status. ClinicalTrials.gov NCT03772743. The Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial has shown that physiology-guided complete revascularization reduces ischaemic adverse events in older patients with myocardial infarction (MI) and multivessel disease. Older patients who engage in light or vigorous physical activity before hospitalization for MI have a reduced risk of the primary composite outcome of death, MI, stroke, or ischaemia-driven revascularization. These benefits extend to all secondary cardiovascular outcomes as well. In the present subanalysis of the FIRE trial, we find that the positive prognosis associated with physiology-guided complete revascularization holds true even for patients with a sedentary lifestyle. This means that this type of revascularization can effectively reduce ischaemic adverse events in older patients with MI and multivessel disease, regardless of their physical activity levels.

Autres résumés

Type: plain-language-summary (eng)
The Functional Assessment in Elderly Myocardial Infarction Patients with Multivessel Disease (FIRE) trial has shown that physiology-guided complete revascularization reduces ischaemic adverse events in older patients with myocardial infarction (MI) and multivessel disease. Older patients who engage in light or vigorous physical activity before hospitalization for MI have a reduced risk of the primary composite outcome of death, MI, stroke, or ischaemia-driven revascularization. These benefits extend to all secondary cardiovascular outcomes as well. In the present subanalysis of the FIRE trial, we find that the positive prognosis associated with physiology-guided complete revascularization holds true even for patients with a sedentary lifestyle. This means that this type of revascularization can effectively reduce ischaemic adverse events in older patients with MI and multivessel disease, regardless of their physical activity levels.

Identifiants

pubmed: 38452238
pii: 7624107
doi: 10.1093/eurjpc/zwae069
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03772743']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Sahajanand Medical Technologies Ltd
Organisme : Medis Medical Imaging Systems
Organisme : Siemens Healthineers
Organisme : General Electric
Organisme : Healthcare, and Insight Lifetech
Organisme : Italian Health Minister
ID : GR 2018-12367114

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Conflict of interest: G.Cam. received research grants and personal fees from ABBOTT VASCULAR, personal fees from MENARINI, personal fees from AMGEN, personal fees from SANOFI, outside the submitted work. S.B. received personal fees from ABBOTT VASCULAR, outside the submitted work.

Auteurs

Rita Pavasini (R)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Gianluca Campo (G)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Matteo Serenelli (M)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Elisabetta Tonet (E)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Vincenzo Guiducci (V)

Cardiology Unit, Azienda USL-IRCCS Reggio Emilia, S. Maria Nuova Hospital, Viale Risorgimento 80, Reggio Emilia 42123, Italy.

Javier Escaned (J)

Cardiovascular Department, Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Calle del Prof Martin Lagos s/n, Madrid 28040, Spain.

Raul Moreno (R)

Interventional Cardiology, University Hospital La Paz, Paseo La Castellana, 261, 28046, Madrid, Spain.

Gianni Casella (G)

Cardiology Unit, Ospedale Maggiore, Largo Nigrisoli 2, Bologna 40133, Italy.

Caterina Cavazza (C)

Cardiovascular Department, Infermi Hospital, Viale Luigi Settembrini 2, Rimini 47923, Italy.

Ferdinando Varbella (F)

Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, and Rivoli Infermi Hospital ASLTO3, Rivoli (TO) 10098, Italy.

Giorgio Sacchetta (G)

Cardiology Unit, Umberto I Hospital, ASP Siracusa, Via Giuseppe Testaferrata, 1, 96100 Siracusa, Italy.

Marco Arena (M)

S.C. Cardiologia, Ospedale Sant'Andrea, ASL5 Liguria, La Spezia 19124, Italy.

Ignacio Amat Santos (IA)

Department of Cardiology, Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Hospital Clínico Universitario, Av. Ramón y Cajal, 3, 47003 Valladolid, Spain.

Enrique Gutiérrez Ibañes (EG)

Department of Cardiology, Centro de Investigation Biomedica end Red en Enfermedades Cardiovasculares, H. Universitario y Politécnico La Fe, Valencia 46026, Spain.

Roberto Scarsini (R)

Cardiovascular Department, Azienda Ospedaliero Universitaria Integrata di Verona, Piazzale Aristide Stefani, 1 - 37126 Verona, Italy.

Gianpiero D'Amico (G)

Interventional Cardiology, Department of Cardio-Thoracic and Vascular Sciences, Ospedale dell'Angelo, Via Paccagnella, 12, 35128 Mestre (Venice), Italy.

Fernando Lozano Ruiz-Poveda (FL)

Cardiovascular Department, Hospital General Universitario de Ciudad Real, 13001, Ciudad Real, Spain.

José Luis Díez Gil (JL)

Cardiology Unit, Hospital San Giovanni di Dio, Azienda Sanitaria Provinciale Agrigento, Agrigento 92100, Italy.

Gianluca Pignatelli (G)

Cardiology Unit, Azienda USL-IRCCS Reggio Emilia, S. Maria Nuova Hospital, Viale Risorgimento 80, Reggio Emilia 42123, Italy.

Gianmarco Iannopollo (G)

Cardiology Unit, Ospedale Maggiore, Largo Nigrisoli 2, Bologna 40133, Italy.

Iginio Colaiori (I)

Cardiology Unit, Ospedale Santa Maria Goretti, Via Lucia Scaravelli, Latina 04100, Italy.

Ramon Calvino Santos (RC)

Department of Interventional Cardiology, Complexo Hospitalario Universitario A Coruña (CHUAC), As Xubias, 84, 15006 A Coruña, Spain.

Andrea Marrone (A)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Luca Fileti (L)

Cardiology Department, S. Maria delle Croci Hospital, Viale Randi 5, Ravenna 48121, Italy.

Stefano Rigattieri (S)

Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035/1039 00189 Roma, Italy.

Emanuele Barbato (E)

Department of Clinical and Molecular Medicine, Sapienza University of Rome, Via di Grottarossa, 1035/1039 00189 Roma, Italy.

Raymundo Ocaranza-Sanchez (R)

Servicio de Cardiología, Hospital Universitario Lucus Augusti, 27001 Lugo, Spain.

Simone Biscaglia (S)

Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Via Aldo Moro 8, Ferrara 44124, Italy.

Classifications MeSH